Currrent EU H2020-related projects

• PECUNIA

• COMED

​

Other programmes and organisations

• AdHopHTA

• Advance HTA

• EMA-EUnetHTA Collaboration

• Decision Analysis Society (INFORMS)

• EURO-HEALTHY

• European Commission

• European Commission: Health Technology Assessment 

• European Commission – Fact Sheet, Q&A Commission Proposal on HTA

• European Network for Health Technology Assessment, EUnetHTA

• European Observatory on Health Systems and Policies

• European Patients' Academy

• European Patients Forum

• European Platform for Rare Disease Registries, EPIRARE

• EuroQol Group

• Health Technology Assessment International, HTAi

• Horizon 2020

• INTEGRATE-HTA

• International Academy of Health Preference Research (IAHPR)

• International Health Economics Association, IHEA

• International Network of Agencies for Health Technology Assessment, INAHTA

• International Society of Pharmacoeconomics and Outcomes Research, ISPOR

• LSE Health

• LSE-NICE Executive MSc in Evaluation of Health Care Interventions and Outcomes (download the programme brochure)

• Medical Technology Research Group, MTRG

• MedtechHTA

• M-MACBETH

• The 10th European Conference on Rare Diseases and Orphan Drugs

• The International Decision Conferencing Forum

​

Regulatory Agencies

• European Medicines Agency

• Food and Drug Administration

• Health Canada

• Therapeutic Goods Administration

• Medicines and Healthcare Products Regulatory Agency (MHRA)

• Agencia Española de Medicamentos y Productos Sanitarios, AEMPS

• Agenzia Italiana del Farmaco, AIFA

 

International Organisations

• World Health Organisation – Health Technologies and Pharmaceuticals Programme

 

Health insurers

• Institut national d'assurance maladie invalidité, INAMI/RIZIV

 

Key HTA Bodies

• Agència de Qualitat i Avaluació Sanitàries de Catalunya, AQuAS (regional)

• Agencja Oceny Technologii Medycznych i Taryfikacji, AOTMiT

• Agenzia Nazionale per i servizi sanitari Regionali, AGENAS

• All Wales Medicines Strategy Group, AWMSG

• Andalusian Agency for Health Technology Assessment, AETSA (regional)

• Basque Office for Health Technology Assessment, OSTEBA (Spain/Regional)

• Belgian Health Care Knowledge Centre, KCE

• Cámara de Instituciones de Diagnostico Médico, CADIME (regional)

• Canadian Agency for Drugs and Technologies in Health, CADTH

• Colombian Institute of Technology Assessment in Health

• Comissão Nacional de Incorporação de Tecnologias no Sus, CONITEC

• Emilia Romagna Region

• Gemeinsamer Bundesausschuss, G-BA

• Haute Autorité de Santé, HAS

• Health Insurance Review and Assessment (HIRA) – South Korea

• Health Intervention and Technology Assessment Program (HITAP) – Thailand

• Health Technology Wales, HTW

• Institut national d'excellence en santé et en services sociaux, INESSS (Quebec)

• Institute for Quality and Efficiency in Health Care, IQWiG

• Instituto de Salud Carlos III, ISCIII

• Lombardia

• National Authority of Medicines and Health Products, I.P., INFARMED

• Pan-Canadian Oncology Drug Review, pCODR

• Pharmaceutical Benefits Advisory Committee, PBAC

• Scottish Health Technologies Group, SHTG

• Scottish Medicines Consortium, SMC

• Servicio, Canario de la Salud, SESCS (Spain/Regional)

• Tandvårds-Läkemedelförmånsverket, TLV

• The National Health Care Institute (Zorginstituut Nederland), ZiN

• The National Institute for Health and Care Excellence, NICE

• The Norwegian Medicines Agency, Statens Iegemiddelverk

• Unidade de Asesoramento Científico-técnico, AVALIA-T (Regional)

• Veneto